Key facts
- This page summarizes Michael Greco V's Form 4 filing for Veradermics, Inc (MANE).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 05 Feb 2026, 19:02.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
The option vests as to 25% of the underlying shares of the Issuer's common stock, par value $0.00001 per share, on February 3, 2027, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal monthly installments over 36 months thereafter, subject to continued service.